13:30 PM-15:20 PM
第一阶段
Phase I
13:30 PM-14:00 PM
第一阶段
Phase I
-
主题报告1
-
Keynote Speech 1
-
中国新，全球新——机遇与挑战
-
The Opportunities and Challenges in Drug Innovation: First in Class or First in China
-
李靖，药渡经纬信息科技（北京）有限公司董事长、联合创始人
-
Jin LI，Founder and Chair of Pharmacodia
14:00 PM-14:30 PM
-
主题报告2
-
Keynote Speech 2
-
以临床价值为导向的抗肿瘤药物临床研发及审评报告
-
Clinical Value-oriented Anti-tumor Drug Clinical Research and Development and Review Report
-
杨志敏，国家药品监督管理局药品审评中心化药临床一部部长
-
YANG Zhimin, Leader of the Medical Review Department I, Centre for Drug Evaluation (CDE), China National Medical Products Administration (NMPA)
15:20 PM-17:00 PM
第二阶段
Phase II
15:20 PM-15:50 PM
-
主题报告1
-
Keynote Speech 1
-
创新药物临床价值体现的重要性
-
The Importance of the Clinical Calue Demonstration for Innovative Drugs
-
宣建伟，中山大学药学院医药经济研究所所长
-
XUAN Jianwei，Director of Health Economics Research Institute, Sun Yat-sen University
15:50 PM-16:10 PM
-
主题报告2
-
Keynote Speech 2
-
商业健康保险与医药创新融合发展的思考
-
Commercial Health Insurance and Access of Innovative Medicine
-
韩世明，波士顿咨询合伙人
-
Samuel HAN，Partner of Boston Consulting Group
16:10 PM-17:00 PM
-
主题讨论
-
Panel
-
满足临床需求，回归临床价值
-
Satisfy Clinical Needs and Return to Clinical Value
Moderator
-
俞卫，上海创奇健康发展研究院执行院长
-
YU Wei，Executive Director,China Healthcare Innovation Platform Academy
Panelists
-
宣建伟， 中山大学药学院医药经济研究所所长
-
翟青， 复旦大学附属上海肿瘤医院药剂科主任
-
李怡平，药明巨诺联合创始人、董事长兼首席执行官
-
韩世明，波士顿咨询合伙人
-
XUAN Jianwei, Director of Health Economics Research Institute, Sun Yat-sen University
-
DI Qing, Director of Pharmacy, Fudan University Affiliated Oncology Hospital
-
James LI, Co-Founder, Chairman and Chief Executive Officer, JW Therapeutics
-
Samuel HAN, Partner of Boston Consulting Group
Conference Affairs Contact
